MilliporeSigma Develops Alternative CRISPR Genome Editing Method
Download PDF Read more
Accelerates development timelines with faster, easier selection and scale up of clones Delivers higher titers of recombinant proteins Billerica, Massachusetts, May 16, 2017 — MilliporeSigma today announced that its CHOZN® expression system will be used by SystImmune, a Seattle-based biotechnology company, for commercial development of a bi-specific antibody therapeutic. The CHOZN® expression system is designed... Read more
Thermo Fisher Scientific Inc. , the world leader in serving science, has expanded its line of endotoxin-free plasmid DNA isolation products with the launch of the PureLink Expi Endotoxin-Free Maxi Plasmid Purification Kit. With a simple and fast protocol for isolation, the kit allows researchers to yield up to 1.5 mg of endotoxin-free, advanced transfection-quality... Read more
WASHINGTON, May 15, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Electrical Products Group Conference in Longboat Key, Florida on Monday, May 22, 2017 at 10:00 a.m. ET. The audio will be simultaneously webcast and the presentation will be archived on... Read more
Approved for Use in Europe to Identify Head and Neck Cancer Patients Most Likely to Benefit from Opdivo (nivolumab) Therapy SANTA CLARA, Calif., May 15, 2017 Agilent Technologies Inc. (NYSE: A) today announced the expanded use of Agilent’s Dako PD-L1 IHC 28-8 pharmDx test for squamous cell carcinoma of the head and neck (SCCHN), the... Read more
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Patheon N.V. (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, today announced that their boards of directors have approved Thermo Fisher’s acquisition of Patheon. Thermo Fisher will commence a tender offer... Read more
Download PDF Read more
May 12, 2017 MilliporeSigma Opens New M Lab™ Collaboration Center in Bangalore Customers can explore new technologies and solutions to address development and manufacturing challenges Simulates a GMP manufacturing environment to accelerate development of new therapies MilliporeSigma, a leading science and technology company, today announced the expansion of its M Lab™ Collaboration Center in Bangalore,... Read more